Important: this page has been automatically translated using AI technology. Please consult your doctor before acting on any health information or email enquiries@arthritis-uk.org for further support.
Read more about a trial of tocilizumab in patients with JIA and associated uveitis who do not respond to anti-TNF treatments.
Learn more about our research into why and how pain experienced during childhood can lead to enhanced sensitivity to pain into adolescence and adulthood.
Read about our research, analysing immune cells of the joint to identify children who are more likely to develop severe JIA.
Learn more about the development of a new ACTH-based treatment that may be effective in reducing joint inflammation
Learn about our research into why communication about pain, between young people with arthritis and their healthcare professional, isn't always effective.
Learn about our research into improving the care service provision and quality of life for young people with arthritis, through promoting service improvement.
Learn more about our research into why our regulatory T cells stop working properly (balancing our immune system) when we have an autoimmune disease e.g. JIA.
Learn about our research into defining subgroups JIA and its associated eye inflammation (uveitis), based on mechanisms of disease or response to treatments.
Learn more about our research into whether there are any predictors of what will happen in the future of a child with juvenile idiopathic arthritis (JIA).
Learn more about identifying new treatments and understanding the long-term effects of enthesitis related arthritis.